US News & World Report
With the delta variant poised to become the dominant strain in the U.S., some Johnson & Johnson recipients are taking an additional shot from Pfizer or Moderna in the hopes of boosting their protection.
Kacie Coats did exactly what all public health experts were telling her to do: She got the first coronavirus vaccine available to her.
he 30-year-old Texas resident was inoculated against COVID-19 with a single Johnson & Johnson shot on March 31, at the first appointment she could get.
“It was, like, when everybody was in the mad dash trying to get appointments and we were told just to get the first available vaccine. So I kind of trusted that it would be good enough,” she says. Then, she began to have doubts. She began reading studies on the effectiveness of the AstraZeneca vaccine, which uses similar technology to J&J’s vaccine, on the delta variant.